Go Back
Advantage Capital
Advantage Capital, based in New Orleans, was founded in 1992. The venture fund invests in various stages from Pre-Seed to Series D, with a diverse focus on sectors like AgTech, CleanTech, Healthcare, and SaaS among others. Steven T. Stull is a key partner at Advantage Capital. The fund has invested in 1123 companies and has seen 117 exits. Some of its portfolio companies include Quoddy, PayIt, Brew Dr. Kombucha, and Recursion Pharmaceuticals. Advantage Capital provides growth equity, lending, and mezzanine debt capital to companies at different development phases.
About
About
About
Bio
Advantage Capital specializes in growth equity, lending, and mezzanine debt capital investment in companies at all stages of development.
Location
New Orleans
Stage
Pre-Seed, Seed, Series A, Series B, Series D, Series C
Partner name
Steven T. Stull
Bio
Advantage Capital specializes in growth equity, lending, and mezzanine debt capital investment in companies at all stages of development.
Location
New Orleans
Stage
Pre-Seed, Seed, Series A, Series B, Series D, Series C
Partner name
Steven T. Stull
Fund
Fund
Fund
Fund Focus
AgTech (FarmTech), ClimateTech & CleanTech, E-Commerce, Healthcare, Impact Investing, IoT (Internet of Things), Life Science, Manufacturing, Oil & Gas, SaaS, Telecommunications (TMT), B2B
Number of investments
1,123
Number of exits
117
Fund Type
Venture Fund
Portfolio Companies
Quoddy, PayIt, Brew Dr. Kombucha, Recursion Pharamaceuticals, PayIt, Cybrexa Therapeutics, FlyGuys, Natural Fiber Welding, Medrhythms
Advantage Capital
Advantage Capital, based in New Orleans, was founded in 1992. The venture fund invests in various stages from Pre-Seed to Series D, with a diverse focus on sectors like AgTech, CleanTech, Healthcare, and SaaS among others. Steven T. Stull is a key partner at Advantage Capital. The fund has invested in 1123 companies and has seen 117 exits. Some of its portfolio companies include Quoddy, PayIt, Brew Dr. Kombucha, and Recursion Pharmaceuticals. Advantage Capital provides growth equity, lending, and mezzanine debt capital to companies at different development phases.
About
Bio
Advantage Capital specializes in growth equity, lending, and mezzanine debt capital investment in companies at all stages of development.
Location
New Orleans
Stage
Pre-Seed, Seed, Series A, Series B, Series D, Series C
Partner name
Steven T. Stull
Fund
Fund Focus
AgTech (FarmTech), ClimateTech & CleanTech, E-Commerce, Healthcare, Impact Investing, IoT (Internet of Things), Life Science, Manufacturing, Oil & Gas, SaaS, Telecommunications (TMT), B2B
Number of investments
1,123
Number of exits
117
Fund Type
Venture Fund
Portfolio Companies
Quoddy, PayIt, Brew Dr. Kombucha, Recursion Pharamaceuticals, PayIt, Cybrexa Therapeutics, FlyGuys, Natural Fiber Welding, Medrhythms